SCHEMBL4351245

SCHEMBL4351245

O=C(NCCc1ccccc1)Nc1cccc(F)c1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.58
RAB9A P51151 7/20 0.57
NPC1 O15118 6/20 0.57
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
KMT2A Q03164 3/20 0.54
MEN1 O00255 1/20 0.54
MAPT P10636 1/20 0.54
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA9 Q16790 1/20 0.52
CCR3 P51677 1/20 0.52
EPHX1 P07099 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
CNR1 P21554 1/20 0.51
HDAC1 Q13547 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6683260 0.87 RAB9A (0.48) TRPV1RAB9ANPC1CYP1A2CYP3A4
SCHEMBL4347160 0.86 KDM4E (0.62) TRPV1RAB9ANPC1KMT2AMEN1
SCHEMBL4347712 0.84 RAB9A (0.60) TRPV1RAB9ANPC1KMT2AMEN1
SCHEMBL4360010 0.83 SMN1; SMN2 (0.64) TRPV1RAB9ANPC1KMT2AMEN1
SCHEMBL4355894 0.83 NPC1 (0.79) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL19472691 0.82 TRPV1 (0.56) TRPV1RAB9ANPC1CYP1A2CYP3A4
SCHEMBL4345936 0.82 MEN1 (0.53) TRPV1RAB9ANPC1CYP1A2CYP3A4
SCHEMBL27782800 0.79 POLB (0.61) MAPTEPHX1SMN1; SMN2
SCHEMBL4347762 0.79 NPC1 (0.59) RAB9ANPC1KMT2AMEN1MAPT
SCHEMBL4349349 0.78 EPHX2 (0.62) EPHX1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 TRPV1 2328/4885RAB9A 4228/4885NPC1 815/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 TRPV1 2320/4885RAB9A 4588/4885NPC1 1189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.